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Abstract
Tracheobronchial submucous glands can be considered the pulmonary equivalent of minor salivary glands and
therefore they can develop most of the tumours originated in these. Nevertheless, in spite of the wide distribution
of this kind of glands along the tracheobronchial tree, pulmonary salivary gland-like neoplasms are not very
frequent. Among them, the most frequent are mucoepidermoid and adenoid cystic carcinomas. On the contrary,
pulmonary neoplasms showing a mixture of epithelial and myoepithelial elements are extraordinary infrequent,
with only 11 cases collected from literature.
We present the case of a 76 year-old woman with no interesting pathological history, to whom a pulmonary
nodule is detected during a study of unknown origin neutropenia. An upper right lobectomy is performed.
After macro and microscopic study, the diagnosis of pulmonary epithelial-myoepithelial tumour is made. It is a low
malignant potential tumour with capacity to locally recur and less frequently to metastasize. Our case has the
peculiarity of not being connected neither to visceral pleura nor to bronchial tree; we have not found this
characteristic in any literature reviewed case.
These tumours have been named in a lot of different ways, including adenomyoepithelioma, epithelial-
myoepithelial tumour, epithelial-myoepithelial carcinoma or epithelial-myoepithelial tumour of uncertain malignant
potential.
The p27/kip-1 protein plays a fundamental role in the development of these neoplasms. As we have verified in our
case, its aberrant cytoplasmic location, besides its proved oncogenic function, would favour the proliferation of
stem cells, which would explain both dual phenotype with presence of myoepithelial cells without connection
with the bronchial tree, and TTF-1 immunostaining in epithelial cells.
Introduction
Epithelial-myoepithelial tumours are rare neoplasms that
occur more frequently in salivary glands, where they
represent approximately 1% of primary tumours. In this
location, they are considered as low malignant potential
tumours with capacity to locally recur and less fre-
quently to metastasize; that is why they are known as
epithelial-myoepithelial carcinoma. Other sites where
these neoplasms can arise are breast and skin.
We present the case of a 76 year-old woman with an
asymptomatic mass in the upper lobe of her right lung,
which was diagnosed as epithelial-myoepithelial tumour.
Myoepithelial cells play a fundamental role in the
development of this kind of tumours. A subcellular
aberrant location of p27/kip-1 inside myoepithelial cells
would provoke loss of their growth-inhibition function
and would contribute to tumorigenesis through lack or
restriction of proliferation of myoepithelial component.
Materials and methods
We present the case of a 76 year-old woman with no
interesting pathological history, to whom a pulmonary
nodule is detected during a study of unknown origin
neutropenia. The patient shows good general aspect. No
palpable adenopathies are detected and cardiopulmonary
auscultation and all physical examinations, electrocar-
diogram and analysis (biochemistry, haemogram and
coagulation study) do not present remarkable findings.
The thoracic TC scan shows an image of a solid pul-
monary nodule with polylobulated outline located in the
upper right lobe (URL). Bronchoscope is normal. After
posterior-lateral thoracotomy, the existence of the
nodule in the URL is proved, so it is decided to perform
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result of it finally required an upper right lobectomy.
Results
Gross study
On gross examination of surgical specimen, it is seen
that the nodule is located in the posterior segment of
the URL and it measures 2,7 cm in its greatest dimen-
sion. The nodule is whitish, homogeneous and well
delimited with regarding surrounding pulmonary
parenchyma.
Microscopic study
Histologically, the tumour is well circumscribed but not
encapsulated, being located into the thickness of pul-
monary parenchyma, without any connection to visceral
pleura or bronchial tree. Neoplastic cells are disposed
forming tubular structures alternating with little cysts
and scant solid areas (Figure 1). Two cellular compo-
nents are recognized, one of cuboid epithelial cells that
line tubules and cysts, with eosinophilic centrally located
nucleus with visible nucleolus and, beneath this one, a
second component from myoepithelial lineage formed
by polygonal cells with abundant clear cytoplasm (Figure
2). The solid areas show a hyaline stroma with polygonal
or slightly spindle cells from myoepithelial lineage. In
the cystic spaces as well as in the tubular structures, a
PAS-positive eosinophilic amorphous material is
observed.
Immunohistochemical study
The epithelial component is positive for keratin (Figure
3), EMA and CEA, while the myoepithelial component
is positive for actin (Figure 4), S-100, p63 and CD10.
Epithelial cells are positive for TTF-1, unlike myoepithe-
lial cells. It is remarkable that the latter show cytoplas-
mic positivity for p27/kip-1 marker (Figure 5). None of
the two components show atypia or mitoses and neither
necrosis nor perineural or vascular invasion are
observed. With all these findings we make the diagnosis
of epithelial-myoepithelial tumour of lung. Nowadays
the patient is in good health and is free of disease.
Discussion
Submucosal tracheobronchial glands can be considered
the pulmonary equivalent of minor salivary glands and,
Figure 1 Neoplastic cells form tubular structures mixed with
little cysts and scarce solid areas.
Figure 2 Two cellular components are recognized, one of
cuboid epithelial cells that line tubules and cysts, with
eosinophilic cytoplasm and central nucleus, with
patentnucleolus; the other component is from myoepithelial
lineage and lies under the former; it consists of polygonal cells
with abundant clear cytoplasm.
Figure 3 The epithelial component is positive for keratin.
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nated from these. Nevertheless, in spite of the wide dis-
tribution of this kind of glands along tracheobronchial
tree, pulmonary salivary gland-like neoplasms are not
very frequent [1]. Among them, the most frequent are
mucoepidermoid and adenoid cystic carcinomas. On the
contrary, pulmonary neoplasms showing a mixture of
epithelial and myoepithelial elements are extraordinary
infrequent, with only 11 cases collected from literature.
All of them came up as polypoid intrabronchial masses,
although our case presents only intraparenchymal
growth, with no apparent bronchial connection.
The epithelial-myoepithelial tumour of the lung
appears mainly in middle-aged people, mostly females
[2,1] but a case of a 7-year-old male has been reported
[12]. This tumour does not seem to be related to cigar-
e t t es m o k i n g ,s i n c eo n l y5 0 %o ft h ep a t i e n t si nt h e
reviewed cases were smokers. The symptoms are very
varied, ranging from asymptomatic cases, as the one we
are presenting, to cough, haemoptysis, thoracic pain,
fever [3], dyspnoea, pneumonia [4], recurrent infections
and others. All patients evolved satisfactorily, without
signs of recurrence nor metastases, and with no need
for adjuvant chemo or radiotherapy, although recently
Nguyen et al. have included the first description of a
case of peribronchial lymph node metastases in a series
of five cases [5]. One of the patients died because of a
carcinoma of the floor of the mouth 36 months after
the diagnose of epithelial-myoepithelial tumour of the
lung was made [6].
Grossly these tumours are not encapsulated but well
delimited masses, and they present an exophytic intrab-
ronchial pattern of growth, sometimes obstructing com-
pletely the bronchial lumina. In most reviewed cases, an
evident relation and connection with the bronchial tree
is observed, but in others, like in our case, it presents as
an intraparenchymatous mass without apparent bron-
chial connection [7]. It is very variable in size, ranging
from 1 cm [8] to 16 cm in the case with the greatest
size [6]. Its colour is whitish or white-greyish and its
surface cut is white and homogeneous, not showing hae-
morrhage or necrosis, but exceptions [6,9].
Microscopically, the tumour was formed by tubules,
cystic areas and solid areas. The proportion of these
components can vary, so both components can be pre-
sent in some cases [10], while in other occasions the
solid component prevails [6] or, on the other hand, it
does not even appear, being replaced by a hyalinized
stroma [8,11]. In other cases it is the tubular component
the one that abounds [4].
The tubules are lined by two cellular components, one
of cuboid epithelial cells next to the lumina, and the
other of myoepithelial cells beneath the first one. Both
in the intercellular spaces and inside the tubules, a PAS-
positive, diastase-sensitive amorphous material is
observed. Necrosis is rare, but it has been described
[6,9]. Exceptionally, areas of atypia and mitoses have
been seen [10,9], but these mitoses are not atypical in
any case. Clear cell areas [4] and squamous metaplasia
[12] have also been described.
Immunohistochemically, the epithelial component is
positive for keratin (Figure 3), EMA and CEA, while
myoepithelial component is positive for S-100, p63 and
CD10. It is remarkable the positivity of epithelial cells
for TTF-1, which suggest that the tumour has a certain
pneumocytic differentiation [13].
Epithelial-myoepithelial tumours of lung are consid-
ered as low malignant potential tumours with capacity
to locally recur and less frequently to metastasize. It has
not been described any case with vascular, lymphatic or
perineural invasion, neither with distant metastasis. The
disease-free survival and lack of nodal involvement cor-
relate well with the lack of recognized histopathologic
features of aggressiveness [14]. As a peculiarity, an
Figure 4 The myoepithelial component is positive for actin.
Figure 5 The myoepithelial component is positive for p27/kip-
1 (cytoplasmic positivity).
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hamartomas has been observed [14].
The differential diagnosis can be extensive and in
many occasions it is going to depend on the relative
predominance of myoepithelial component or on the
biphasic pattern. The neoplasms that can be most fre-
quently confused with epithelial-myoepithelial tumours
of the lung are mixed tumour (pleomorphic adenoma),
bronchial adenoma, adenoid cystic carcinoma, clear cell
tumour of lung ("sugar tumour”) and metastatic lesions,
mainly those from salivary gland and kidney.
Although there is mutual agreement between the dif-
ferent authors about considering this neoplasia of low
grade malignancy, this kind of tumour has been desig-
nated in many different ways, including adenomyoe-
pithelioma, epithelial-myoepithelial tumour, epithelial-
myoepithelial carcinoma or epithelial-myoepithelial
tumour of uncertain malignant potential. Despite the
fact that most cases described until now have presented
no local recurrence or metastasis, and taking into
account that they are generally of small size and use to
lack atypia, remarkable mitotic activity, necrosis or inva-
sive features, the metastatic potential found in some of
them [5] would make the term of carcinoma epithelial-
myoepithelial adequate, even when the following terms
of the patients are relatively short.
Pelosi et al., based on a different immunostain pattern
between the two neoplastic components both for ki67
and p27/kip-1, suggest that myoepithelial cells play a
fundamental role in the development of this kind of
tumour [3]. Protein p27/kip-1 is a cycline-dependent
kinase inhibitor (CDK) that blocks cell cycle in G0 and
G1. It is present in high concentration in quiescent cells
and its levels slowly decrease while cells are stimulated
to begin the cell cycle. Thus, p27/kip-1 inhibits and con-
trols the progression of the cell cycle and therefore exer-
cises a function of inhibition of tumorigenesis; in fact, it
has been demonstrated that levels of p27/kip-1 are
decreased in many tumours. Moreover, Besson et al.
have recently described a dual function of this protein;
as well as acting as an inhibitor of tumorigenesis, it
would have oncogenic functions when it presents cyto-
plasmic location, acting through mediators which are lit-
tle known [15]. The work also suggests that p27/kip-1
oncogenic activity leads to aberrant stem and progenitor
cell expansion in the lung and retina. This study pro-
vides the first direct in vivo evidence that in addition to
its role as a tumor suppressor, p27/kip-1 also functions
as an oncogene. So, in epithelial-myoepithelial tumours
of lung, in accordance with Pelosi et al. [3], an aberrant
subcellular location of p27/kip-1 into the myoepithelial
cell would provoke the loss of its growth-inhibition
function through the lack of restriction of proliferation
of myoepithelial component, which joined to the p27/
kip-1’s new “dark side” may serve an oncogenic function
that operates in less specialized cell types to influence
tumorigenesis [16].
In conclusion, we can assess that epithelial-myoepithe-
lial tumour is a neoplasia of uncertain malignant poten-
tial, which exceptionally can arise in the lung. Our case
presents the peculiarity that it has no relation with visc-
eral pleura or bronchial tree, not having found this fea-
ture in any of the literature reviewed cases. We agree
with Pelosi et al. that the protein p27/kip-1 plays a fun-
damental role in development of these tumours. As we
have checked in our case, its aberrant cytoplasmic loca-
tion, along with its proved oncogenic function, would
favour proliferation of STEM cells, which would explain
both dual phenotype with presence of myoepithelial
cells without connection with bronchial tree, and TTF-1
positivity in epithelial cells.
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